DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma

✍ Scribed by Martin Kropff; Peter Liebisch; Stefan Knop; Katja Weisel; Hannes Wand; Claudia-Nanette Gann; Wolfgang E. Berdel; Herrmann Einsele; on behalf of the Deutsche Studiengruppe Multiples Myelom, DSMM

• Publisher: Springer
• Year: 2009
• Tongue: English
• Weight: 125 KB
• Volume: 88
• Category: Article
• ISSN: 0939-5555
• DOI: 10.1007/s00277-009-0726-6